Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
36%
OVERLAP
BY WEIGHT
29
# OF OVERLAPPING
HOLDINGS
HELX
70
HOLDINGS
43%
ALSO IN WDNA
WDNA
85
HOLDINGS
35%
ALSO IN HELX
SECTOR DRIFT (HELX minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HELX |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 6.2% | 4.4% | 4.4% |
|
ALNYLAM PHARMACEUTICALS INC | 3.6% | 3.0% | 3.0% |
|
BRIDGEBIO PHARMA, INC. | 2.4% | 4.0% | 2.4% |
|
ELI LILLY & CO | 2.9% | 2.3% | 2.3% |
|
UNITED THERAPEUTICS CORP | 3.5% | 2.2% | 2.2% |
HELX Overweight Relative to WDNA
|
MEDPACE HOLDINGS, INC. | 5.3% |
|
INSMED INC | 4.6% |
|
KRYSTAL BIOTECH, INC. | 4.0% |
 |
SAMSUNG BIOLOGICS CO., LTD. | 3.6% |
|
GUARDANT HEALTH, INC. | 2.7% |
|
CADENCE DESIGN SYS INC | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.4% |
|
LIGAND PHARMACEUTICALS-CL B | 2.3% |
|
REGENERON PHARMACEUTICALS | 2.3% |
 |
SARTORIUS AG PREF | 2.1% |
HELX Underweight Relative to WDNA
|
BLUEPRINT MEDICINES CORP. | -3.8% |
 |
NOVOZYMES A/S-B SHARES | -3.2% |
|
STOKE THERAPEUTICS, INC. | -2.3% |
|
AGIOS PHARMACEUTICALS INC | -2.1% |
 |
NOVARTIS AG | -1.9% |
|
GILEAD SCIENCES INC | -1.9% |
|
VERICEL CORPORATION | -1.8% |
|
BRIDGEBIO PHARMA, INC. | -1.6% |
|
JOHNSON & JOHNSON | -1.5% |
|
DUPONT DE NEMOURS INC | -1.5% |